Chris Achar
Directeur/Membre du Conseil chez CUE HEALTH INC.
Fortune : 293 307 $ au 30/04/2024
Profil
Mr. Chris K.
Achar is a Director & Chief Business Officer at Cue Health, Inc., a Chief Executive Officer at GenZum Life Sciences LLC and a Chief Executive Officer at Genzum Life Sciences, Inc. He is on the Board of Directors at Cue Health, Inc. and The Network for Teaching Entrepreneurship.
He received his undergraduate degree from The California State University and an MBA from Pepperdine Graziadio Business School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CUE HEALTH INC.
1,27% | 31/03/2024 | 2 008 950 ( 1,27% ) | 293 307 $ | 30/04/2024 |
Postes actifs de Chris Achar
Sociétés | Poste | Début |
---|---|---|
CUE HEALTH INC. | Directeur/Membre du Conseil | 01/05/2018 |
Genzum Life Sciences, Inc. | Directeur Général | 01/01/2020 |
The Network for Teaching Entrepreneurship
The Network for Teaching Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Network for Teaching Entrepreneurship (NFTE) is a non-profit organization that provides entrepreneurship education to middle school, high school, and postsecondary students in 30 states and 31 countries. The non-profit company is based in New York, NY. NFTE aims to ignite the entrepreneurial mindset in students, empowering them to own their futures regardless of their family income, community resources, special needs, gender identity, race, or ethnicity. NFTE has educated over a million students through in-school, out-of-school, in-person, online, or hybrid programs. The company was founded in 1987 by Carl Press and Philip A. McNeill, and J.D. LaRock has been the CEO of the company since 2019. | Directeur/Membre du Conseil | 01/01/2018 |
GenZum Life Sciences LLC
GenZum Life Sciences LLC Pharmaceuticals: MajorHealth Technology GenZum Life Sciences LLC operates as a pharmaceutical product development and out licensing company. It operates throughout the pharmaceutical development cycle and from product selection and formulation to clinical trials and FDA approval, Genzum product lines have been in-licensed by pharmaceutical companies, decreasing costs, increasing market value and improving the lives of many. The firm utilizes an innovative ecosystem of best in class facilities and expert pharmaceutical development and clinical trials capabilities. The company was founded by Rajin K. Ahuja and Chris K. Achar in 2008 and is headquartered in Los Angeles, CA. | Directeur Général | 01/01/2010 |
Formation de Chris Achar
The California State University | Undergraduate Degree |
Pepperdine Graziadio Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CUE HEALTH INC. | Health Technology |
Entreprise privées | 3 |
---|---|
The Network for Teaching Entrepreneurship
The Network for Teaching Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Network for Teaching Entrepreneurship (NFTE) is a non-profit organization that provides entrepreneurship education to middle school, high school, and postsecondary students in 30 states and 31 countries. The non-profit company is based in New York, NY. NFTE aims to ignite the entrepreneurial mindset in students, empowering them to own their futures regardless of their family income, community resources, special needs, gender identity, race, or ethnicity. NFTE has educated over a million students through in-school, out-of-school, in-person, online, or hybrid programs. The company was founded in 1987 by Carl Press and Philip A. McNeill, and J.D. LaRock has been the CEO of the company since 2019. | Commercial Services |
GenZum Life Sciences LLC
GenZum Life Sciences LLC Pharmaceuticals: MajorHealth Technology GenZum Life Sciences LLC operates as a pharmaceutical product development and out licensing company. It operates throughout the pharmaceutical development cycle and from product selection and formulation to clinical trials and FDA approval, Genzum product lines have been in-licensed by pharmaceutical companies, decreasing costs, increasing market value and improving the lives of many. The firm utilizes an innovative ecosystem of best in class facilities and expert pharmaceutical development and clinical trials capabilities. The company was founded by Rajin K. Ahuja and Chris K. Achar in 2008 and is headquartered in Los Angeles, CA. | Health Technology |
Genzum Life Sciences, Inc. |